Deutsche Bank AG restated their buy rating on shares of Tenet Healthcare Corporation (NYSE:THC) in a report published on Friday. They currently have a $24.00 price objective on the stock.

Other research analysts have also issued research reports about the stock. Jefferies Group LLC reiterated a buy rating and issued a $24.00 price objective (down previously from $26.00) on shares of Tenet Healthcare Corporation in a report on Tuesday, August 8th. Robert W. Baird reiterated a buy rating and issued a $23.00 price objective on shares of Tenet Healthcare Corporation in a report on Thursday, August 24th. Morgan Stanley initiated coverage on shares of Tenet Healthcare Corporation in a report on Tuesday, June 6th. They issued an equal weight rating and a $19.00 price objective for the company. Royal Bank Of Canada reiterated a hold rating and issued a $25.00 price objective on shares of Tenet Healthcare Corporation in a report on Tuesday, July 18th. Finally, Credit Suisse Group dropped their price objective on shares of Tenet Healthcare Corporation from $20.00 to $17.00 and set a neutral rating for the company in a report on Wednesday, August 9th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of $21.43.

Tenet Healthcare Corporation (NYSE THC) traded up 5.53% during midday trading on Friday, hitting $18.12. 5,345,962 shares of the company were exchanged. The stock’s market capitalization is $1.83 billion. Tenet Healthcare Corporation has a one year low of $12.54 and a one year high of $24.86. The firm’s 50-day moving average price is $16.83 and its 200-day moving average price is $17.76.

Tenet Healthcare Corporation (NYSE:THC) last issued its quarterly earnings data on Monday, August 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.17). The business had revenue of $14.80 billion during the quarter, compared to analyst estimates of $4.90 billion. Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The firm’s quarterly revenue was up 204.1% on a year-over-year basis. During the same quarter last year, the business earned $0.38 EPS. Equities research analysts anticipate that Tenet Healthcare Corporation will post $0.83 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Deutsche Bank AG Reaffirms “Buy” Rating for Tenet Healthcare Corporation (THC)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/09/04/deutsche-bank-ag-reaffirms-buy-rating-for-tenet-healthcare-corporation-thc.html.

Several large investors have recently added to or reduced their stakes in THC. Bank of Montreal Can increased its stake in shares of Tenet Healthcare Corporation by 119.3% in the 1st quarter. Bank of Montreal Can now owns 12,667 shares of the company’s stock valued at $223,000 after acquiring an additional 6,892 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of Tenet Healthcare Corporation by 2.5% in the 1st quarter. Louisiana State Employees Retirement System now owns 20,200 shares of the company’s stock valued at $358,000 after acquiring an additional 500 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Tenet Healthcare Corporation by 986.7% in the 1st quarter. Nisa Investment Advisors LLC now owns 16,300 shares of the company’s stock valued at $289,000 after acquiring an additional 14,800 shares in the last quarter. Nationwide Fund Advisors increased its stake in shares of Tenet Healthcare Corporation by 0.7% in the 1st quarter. Nationwide Fund Advisors now owns 132,283 shares of the company’s stock valued at $2,343,000 after acquiring an additional 968 shares in the last quarter. Finally, First Mercantile Trust Co. increased its stake in shares of Tenet Healthcare Corporation by 23.8% in the 1st quarter. First Mercantile Trust Co. now owns 9,900 shares of the company’s stock valued at $175,000 after acquiring an additional 1,900 shares in the last quarter.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Analyst Recommendations for Tenet Healthcare Corporation (NYSE:THC)

Receive News & Stock Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related stocks with our FREE daily email newsletter.